Safety and immunogenicity of the third (booster) dose of inactivated and recombinant protein SARS-CoV-2 vaccine for patients with endocrine-related cancer

• Κύριοι συγγραφείς: Shanshan Han (Συγγραφέας), Yuping Yang (Συγγραφέας), Tingrui Wang (Συγγραφέας), Rui Song (Συγγραφέας), Daixing Hu (Συγγραφέας), Mingli Peng (Συγγραφέας), Zijing Lin (Συγγραφέας), Qin Deng (Συγγραφέας), Hong Ren (Συγγραφέας), Jia Ming (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Frontiers Media S.A., 2023-02-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

BackgroundOur study aimed to evaluate the safety and immunogenicity of the third (booster) dose of the COVID-19 vaccine for patients with endocrine-related cancers.MethodsThis observational study involved 94 breast cancer patients, 92 thyroid cancer patients, and 123 healthy individuals who had rece...